Vgenomics

Noida, India Founded: 2021 • Age: 5 yrs
Diagnostic and therapeutic solutions for inborn diseases are developed.
Annual revenue $22,771 Latest available
Total funding - 1 rounds
Employees 1 Tracked headcount
Investors 4 Known backers
Products 3 Services tracked
Competitors 11 Brand Intelligence

About Vgenomics

Vgenomics is a company based in Noida (India) founded in 2021 by Rahila Sardar, Sameer Malik, and Preeti Gupta Lal. The company has 1 employees as of March 23, 2024. Vgenomics offers products and services including Genomic Sequencing, Comprehensive Blood Test, and Therapeutics Tools. Vgenomics operates in a competitive market with competitors including Omniome, Novogene Corporation, Baebies, HitGen and Singular Genomics, among others.

  • Headquarter Noida, India
  • Employees 1 as on 23 Mar, 2024
  • Founders Rahila Sardar, Sameer Malik, Preeti Gupta Lal
  • Stage Minicorn
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Vgenomics India Private Limited
  • Date of Incorporation 21 Apr, 2022
  • Jurisdiction Delhi, Delhi, India
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $22.77 K (USD)
    0
    as on Mar 31, 2023
  • Net Profit
    -$10.89 K (USD)
    0
    as on Mar 31, 2023
  • EBITDA
    -$10.89 K (USD)
    0
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    1

    as on Mar 23, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Vgenomics

Vgenomics offers a comprehensive portfolio of products and services, including Genomic Sequencing, Comprehensive Blood Test, and Therapeutics Tools.

Product name locked
Category locked
Primary

Service for analyzing genetic data to diagnose rare diseases.

Product name locked
Category locked
Locked

Test panel for screening over 100 rare diseases in newborns.

Product name locked
Category locked
Locked

Proprietary tools to speed up development of treatments for rare diseases.

Funding Insights of Vgenomics

Investors in Vgenomics

Vgenomics has secured backing from 4 investors, including venture fund and angel investors. Prominent investors backing the company include Mumbai Angels, O2 Angels Network and Rohit Chanana.

All
Venture Fund
Angel
Investor Description Founded Year Domain Location
Early-stage venture investments are facilitated by Mumbai Angels network.
Locked Locked Locked
Angel network focused on multiple sectors
Locked Locked Locked

Rohit Chanana

Angel investor, ex-SVP at Hero MotoCorp, focused on startups
Locked Locked Locked
Premium access

Investor details for Vgenomics

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Vgenomics

Investments
Premium access

Investment portfolio details for Vgenomics

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Vgenomics

Premium access

Detailed financials for Vgenomics

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Vgenomics Comparisons

Vgenomics Primary company
Description
Diagnostic and therapeutic solutions for inborn diseases are...
Location
Noida, India
Founded Year
2021
Annual Revenue
$22.77 K (USD)
Net Profit
-$10.89 K (USD)
EBITDA
-$10.89 K (USD)
Employees
1
As of 2024
Premium access

Peer comparison for Vgenomics

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Vgenomics

Vgenomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Omniome, Novogene Corporation, Baebies, HitGen and Singular Genomics, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Genome sequencing platform is provided for clinical diagnostics.
Locked Locked Locked
Genomic services and solutions with NGS expertise are provided.
Locked Locked Locked
Provider of diagnostic products for pediatrics
Locked Locked Locked
DNA-encoded libraries are developed for drug discovery applications.
Locked Locked Locked
Next-generation gene sequencing and multi-omics technologies are provided.
Locked Locked Locked
Next-generation sequencing and genomics services are provided globally.
Premium access

Detailed competitors of Vgenomics

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Vgenomics

Premium access

Complete news archive for Vgenomics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vgenomics

Vgenomics was founded in 2021 and raised its 1st funding round 3 years after it was founded.

Vgenomics is headquartered in Noida, India. It is registered at Noida, Uttar Pradesh, India.

Rahila Sardar is the current CEO of Vgenomics. They have also founded this company.

As of Mar 23, 2024, the latest employee count at Vgenomics is 1.

Annual revenue of Vgenomics is $22.77K as on Mar 31, 2023.

Vgenomics was founded in 2021 and is based in Noida, India, where diagnostic and therapeutic solutions for inborn diseases are developed. A comprehensive blood test is offered alongside therapeutic options for rare inborn conditions. Precise whole exome sequencing, RNAseq, and bioinformatics analysis services are also provided to support research and clinical applications in the genomics sector.

Vgenomics's top competitors include Novogene Corporation, Baebies and Singular Genomics.

Vgenomics offers Genomic Sequencing, Comprehensive Blood Test, and Therapeutics Tools.

Vgenomics has 4 investors. Key investors include Mumbai Angels, O2 Angels Network, Rohit Chanana, and Sabine Kapasi.

The valuation of Vgenomics is $4.29M as of Jan 2024.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available